INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
07/16/2026
Back to search
Official data from USPTO
BOND
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BOND
ST13
US500000079211754Class
5, 9, 10, 42
Filing
79211754
Registration
5577742
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
56
Latest update
07/16/2026
Trademark type
Word
Nice classes
5, 9, 10, 42
Filing date
04/04/2017
Registration date
10/09/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/18/2025
Last transaction
07/16/2026
Responsible office
United States Patent and Trademark Office
Status code
708
Official register
Principal Register
Drawing code
4
Owner type
82
Owner location
VIC, AU
Examiner
FIRST, VIVIAN M
Current location
Historical data usage
Holders and representatives
Holders
Leica Biosystems Melbourne Pty Ltd
Leica Biosystems Melbourne Pty Ltd
Representatives
Jessica G. McDonald Schwegman Lundberg & Woessner P.A.
Technical classification
Nice Classes
Class 5Class 9Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationspharmaceutical preparations for histological and cytological tissue processing applications and reagents for medical and medical diagnostic purposes; diagnostic preparations for medical use; reagents containing primary antibodies for medical use; chemical reagents and diagnostic preparations for medical and veterinary purposes; medical diagnostic reagents; clinical medical reagents; reagents for immuno-histochemistry detection and in situ-hybridisation detection for medical use; doubletriple or multiple in situ hybridisation probes for application of multiple antibodies or probes in the same staining procedure to a tissue section during IHC staining for medicalresearch or veterinary purposes; epitope retrieval solutions for medical use; enzymes and enzyme preparations for medical and diagnostic purposes; diagnostic histological dye and stain solutions for medical use; dewaxing and wash buffers used with the aforementioned preparations for use in disease testing; diagnostic preparations for clinical or medical laboratory use
Class 9
Diagnostic apparatus and instrumentsnot for medical purposesincludingapparatus for staining and/or visualization of tissue or cell based samples for diagnostic or scientific use; apparatus for detection of tissue and/or cell based samples not for medical purposes; recorded and downloadable software for identifying and diagnosing cancer and other diseases and processing digital images; analysis apparatus for laboratory use for analyzing the results of tissues and cell based samples obtained through operation of tissue and cell sample staining apparatus; measuring apparatus used to identify and/or diagnose cancer and other diseasesnot for medical use; diagnostic testing apparatus incorporating chemical reagents not for medical use
Class 10
Apparatus for detection of tissue and/or cell based samplesall for medical purposes; histopathology instruments; haematology instruments for clinical purposesnamely tissue staining instruments; diagnostic medical apparatus for performing immunohistochemistry and in situ-hybridisation staining reactionshistological and pathological staining; in situ hybridisation probes; apparatus for medical use promoting and controlling reaction on microarrays or under slide covertiles used in conjunction with histopathology instrumentstissue staining instruments and diagnostic medical apparatus for performing immunohistochemistry and in situ hybridisation staining reactions and histological and pathological staining; in-vitro diagnostic testing apparatus incorporating chemical reagents for medical use; medical specimen collection slides for specimen collection in surgery
Class 42
Medical research; installation and integration of computer softwareincluding within existing hospital and laboratory infrastructure; maintenanceupdating and upgrading of software; all the aforementioned for use in connection with medical analysisdiagnosis and research
Publications
History of USPTO decisions and trademark events.
56 publications found
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
06/16/2026
INPC
INVALIDATION PROCESSED
06/16/2026
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
11/18/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/10/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/10/2025
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
10/10/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/10/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/10/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/10/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/10/2025
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
03/18/2025
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
03/18/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/10/2025
ES75
TEAS SECTION 71 & 15 RECEIVED
10/08/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/09/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/08/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/18/2019
FIMP
FINAL DISPOSITION PROCESSED
01/18/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/09/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
10/09/2018
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
09/05/2018
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
07/24/2018
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
07/16/2018
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
07/13/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/26/2018
PUBO
PUBLISHED FOR OPPOSITION
06/26/2018
GPNX
NOTIFICATION PROCESSED BY IB
06/23/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/06/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/06/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/06/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/24/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/24/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/24/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/24/2018
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
03/13/2018
GNSF
SUBSEQUENT FINAL EMAILED
03/13/2018
CFRC
SUBSEQUENT FINAL REFUSAL WRITTEN
03/13/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/07/2018
GNFR
FINAL REFUSAL E-MAILED
02/07/2018
CNFR
FINAL REFUSAL WRITTEN
02/07/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/19/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/18/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/18/2018
ATRV
ATTORNEY REVIEW COMPLETED
11/30/2017
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
11/15/2017
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
10/27/2017
RFNT
REFUSAL PROCESSED BY IB
08/04/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/20/2017
RFRR
REFUSAL PROCESSED BY MPU
07/20/2017
MAFR
APPLICATION FILING RECEIPT MAILED
07/15/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/14/2017
CNRT
NON-FINAL ACTION WRITTEN
07/13/2017
DOCK
ASSIGNED TO EXAMINER
07/11/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/11/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/06/2017
Continuous trademark protection
Get notified about every new filing that threatens BOND or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.